A-272651, a nonpeptidic blocker of large-conductance Ca2+-activated K+ channels, modulates bladder smooth muscle contractility and neuronal action potentials

Br J Pharmacol. 2007 Jul;151(6):798-806. doi: 10.1038/sj.bjp.0707278. Epub 2007 May 21.

Abstract

Background and purpose: The large-conductance Ca(2+)-activated K(+) channel (BK(Ca), K(Ca)1.1) links membrane excitability with intracellular Ca(2+) signaling and plays important roles in smooth muscle contraction, neuronal firing, and neuroendocrine secretion. This study reports the characterization of a novel BK(Ca) channel blocker, 2,4-dimethoxy-N-naphthalen-2-yl-benzamide (A-272651).

Experimental approach: (86)Rb(+) efflux in HEK-293 cells expressing BK(Ca) was measured. Effects of A-272651 on BK(Ca) alpha- and BK(Ca) alphabeta1-mediated currents were evaluated by patch-clamp. Effects on contractility were assessed using low-frequency electrical field stimulated pig detrusor and spontaneously contracting guinea pig detrusor. Effects of A-272651 on neuronal activity were determined in rat small diameter dorsal root ganglia (DRG).

Key results: A-272651 (10 microM) inhibited (86)Rb(+) efflux evoked by NS-1608 in HEK-293 cells expressing BK(Ca) currents. A-272651 concentration-dependently inhibited BK(Ca) currents with IC(50) values of 4.59 microM (Hill coefficient 1.04, measured at +40 mV), and 2.82 microM (Hill coefficient 0.89), respectively, for BK(Ca) alpha and BK(Ca) alphabeta1-mediated currents. Like iberiotoxin, A-272651 enhanced field stimulated twitch responses in pig detrusor and spontaneous contractions in guinea pig detrusor with EC(50) values of 4.05+/-0.05 and 37.95+/-0.12 microM, respectively. In capsaicin-sensitive DRG neurons, application of A-272651 increased action potential firing and prolonged action potential duration.

Conclusions and implications: These data demonstrate that A-272651 modulates smooth muscle contractility and neuronal firing properties. Unlike previously reported peptide BK(Ca) blockers, A-272651 represents one of the first small molecule BK(Ca) channel blockers that could serve as a useful tool for further characterization of BK(Ca) channels in physiological and pathological states.

MeSH terms

  • Action Potentials / drug effects*
  • Animals
  • Benzamides / administration & dosage
  • Benzamides / pharmacology*
  • Dose-Response Relationship, Drug
  • Electrophysiology
  • Ganglia, Spinal
  • Guinea Pigs
  • Humans
  • In Vitro Techniques
  • Inhibitory Concentration 50
  • Large-Conductance Calcium-Activated Potassium Channels / antagonists & inhibitors*
  • Muscle Contraction / drug effects*
  • Muscle, Smooth / drug effects
  • Naphthalenes / administration & dosage
  • Naphthalenes / pharmacology*
  • Neurons / drug effects
  • Neurons / metabolism
  • Peptides / pharmacology
  • Radioligand Assay
  • Rats
  • Rats, Sprague-Dawley
  • Swine
  • Urinary Bladder / drug effects*
  • Urinary Bladder / innervation
  • Urinary Bladder / metabolism

Substances

  • 2,4-dimethoxy-N-naphthalen-2-yl-benzamide
  • Benzamides
  • Large-Conductance Calcium-Activated Potassium Channels
  • Naphthalenes
  • Peptides
  • iberiotoxin